Dopaminergic Modulation of Risk-Based Decision Making

Psychopharmacological studies have implicated the mesolimbic dopamine (DA) system in the mediation of cost/benefit evaluations about delay or effort-related costs associated with larger rewards. However, the role of DA in risk-based decision making remains relatively unexplored. The present study in...

Full description

Saved in:

Bibliographic Details
Published in:	Neuropsychopharmacology (New York, N.Y.) Vol. 34; no. 3; pp. 681 - 697
Main Authors:	ONGE, Jennifer R. St, FLORESCO, Stan B
Format:	Journal Article
Language:	English
Published:	Basingstoke Nature Publishing Group 01-02-2009
Subjects:	Adult and adolescent clinical studies Amphetamines Animals Behavior, Animal - drug effects Behavior, Animal - physiology Benzamides - pharmacology Benzazepines - pharmacology Benzopyrans - pharmacology Biological and medical sciences Brain research Bromocriptine - pharmacology Conditioning, Operant - drug effects Decision making Decision Making - drug effects Decision Making - physiology Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Dextroamphetamine - pharmacology Dopamine Dopamine Agonists - pharmacology Dopamine Antagonists - pharmacology Dopamine D2 Receptor Antagonists Gambling Medical sciences Naphthalenes - pharmacology Nervous system (semeiology, syndromes) Nervous system as a whole Neurology Neuropharmacology Organic mental disorders. Neuropsychology Oxazines - pharmacology Parkinson's disease Pharmacology. Drug treatments Piperazines - pharmacology Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Pyridines - pharmacology Pyrroles - pharmacology Pyrrolidines - pharmacology Rats Rats, Long-Evans Receptors, Dopamine D1 - agonists Receptors, Dopamine D1 - antagonists & inhibitors Receptors, Dopamine D2 - agonists Receptors, Dopamine D3 - agonists Receptors, Dopamine D3 - antagonists & inhibitors Receptors, Dopamine D4 - agonists Receptors, Dopamine D4 - antagonists & inhibitors Reinforcement Schedule Restless legs syndrome Risk Salicylamides - pharmacology Canada Amphetamine derivatives Nervous system diseases Dopamine Parkinson's disease CNS stimulant Decision making Psychotropic D3 receptors Parkinson disease amphetamine gambling Catecholamine Gambling game D3 Dopamine receptor Cerebral disorder Discounting D2 Dopamine receptor Central nervous system disease Risk factor Neurotransmitter Amfetamine D2 receptors Degenerative disease Extrapyramidal syndrome
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!